Evaluate the Safety of Recombinant Activated Factor VII in Subjects with Brain Contusions Within the first 15 days of injury [clinicaltrials_resource:d1f2660f9079f3cceb710db2840643df]

Evaluate the Safety of Recombinant Activated Factor VII in Subjects with Brain Contusions Within the first 15 days of injury [clinicaltrials_resource:d1f2660f9079f3cceb710db2840643df]

Clinical Trials at Novo Nordisk
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:d1f2660f9079f3cceb710db2840643df
Safety and Preliminary Efficacy of Recombinant Activated Factor VII in Subjects With Traumatic Brain Injury [clinicaltrials:NCT00123591]
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Evaluate the Safety of Recombinant Activated Factor VII in Subjects with Brain Contusions Within the first 15 days of injury [clinicaltrials_resource:d1f2660f9079f3cceb710db2840643df]

Clinical Trials at Novo Nordisk
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:d1f2660f9079f3cceb710db2840643df
Bio2RDF identifier
d1f2660f9079f3cceb710db2840643df
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d1f2660f9079f3cceb710db2840643df
measure [clinicaltrials_vocabulary:measure]
Evaluate the Safety of Recombinant Activated Factor VII in Subjects with Brain Contusions
time frame [clinicaltrials_vocabulary:time-frame]
Within the first 15 days of injury
description
Clinical Trials at Novo Nordisk
identifier
clinicaltrials_resource:d1f2660f9079f3cceb710db2840643df
title
Evaluate the Safety of Recombi ...... in the first 15 days of injury
@en
inDataset
type
label
Evaluate the Safety of Recombi ...... 2660f9079f3cceb710db2840643df]
@en